Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06411925
PHASE4

The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients

Sponsor: SamA Pharmaceutical Co., Ltd

View on ClinicalTrials.gov

Summary

Clinical Study to Evaluate the Efficacy and Safety of Atock Dry Syrup with Acute bronchial Patients

Official title: A Multi-center, Randomized, Double-blinded, Active-controlled, Non-inferiority, Phase 4 Trial to Evaluate the Efficacy and Safety of Atock Dry Syrup Sama With Acute Bronchitis Patients

Key Details

Gender

All

Age Range

6 Months - 11 Years

Study Type

INTERVENTIONAL

Enrollment

296

Start Date

2023-11-10

Completion Date

2027-09

Last Updated

2025-09-23

Healthy Volunteers

No

Interventions

DRUG

Atock Dry Syrup with placebo patch

Atock Dry syrup (TID) with placebo patch (QD)

DRUG

Tulobuterol patch with placebo dry syrup

Tulobuterol patch (QD) with placebo dry syrup (TID)

Locations (1)

Soonchunhyang University Seoul Hospital

Seoul, South Korea